Kovatchev BP. Metrics for glycaemic control - from HbA1c to continuous glucose monitoring. Nat Rev Endocrinol. 2017;13(7):425–36. https://doi.org/10.1038/nrendo.2017.3.
Article CAS PubMed Google Scholar
Martinez M, Santamarina J, Pavesi A, et al. Glycemic variability and cardiovascular disease in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1):e002032. https://doi.org/10.1136/bmjdrc-2020-002032.
Article PubMed PubMed Central Google Scholar
Agarwal S, Simmonds I, Myers AK. The use of diabetes technology to address inequity in health outcomes: limitations and opportunities. Curr Diab Rep. 2022;22(7):275–81. https://doi.org/10.1007/s11892-022-01470-3.
Article PubMed PubMed Central Google Scholar
American Diabetes Association. 7 Diabetes technology: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S71–80. https://doi.org/10.2337/dc19-S007.
Fleming GA, Petrie JR, Bergenstal RM, et al. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) diabetes technology working group. Diabetologia. 2020;63(2):229–41. https://doi.org/10.1007/s00125-019-05034-1.
Toschi E, Munshi MN. Benefits and challenges of diabetes technology use in older adults. Endocrinol Metab Clin North Am. 2020;49(1):57–67. https://doi.org/10.1016/j.ecl.2019.10.001.
Sim R, Lee SWH. Patient preference and satisfaction with the use of telemedicine for glycemic control in patients with type 2 diabetes: a review. Patient Prefer Adherence. 2021;15:283–98. https://doi.org/10.2147/PPA.S271449.
Article PubMed PubMed Central Google Scholar
Al-Nozha OM, Alshareef EK, Aljawi AF, et al. Diabetic patients’ perspective about new technologies used in managing diabetes mellitus in Saudi Arabia: a cross-sectional study. Cureus. 2022;14(5):e25038. https://doi.org/10.7759/cureus.25038.
Article PubMed PubMed Central Google Scholar
Freckmann G, Buck S, Waldenmaier D, et al. Insulin pump therapy for patients with type 2 diabetes mellitus: evidence, current barriers, and new technologies. J Diabetes Sci Technol. 2021;15(4):901–15. https://doi.org/10.1177/1932296820928100.
Article CAS PubMed Google Scholar
Alsairafi ZK, Smith FJ, Taylor KMG, et al. A qualitative study exploring patients’ experiences regarding insulin pump use. Saudi Pharm J. 2018;26(4):487–95. https://doi.org/10.1016/j.jsps.2018.02.010.
Article PubMed PubMed Central Google Scholar
Ghazanfar H, Rizvi SW, Khurram A, et al. Impact of insulin pump on quality of life of diabetic patients. Indian J Endocrinol Metab. 2016;20(4):506–11. https://doi.org/10.4103/2230-8210.183472.
Article CAS PubMed PubMed Central Google Scholar
Johnston AR, Poll JB, Hays EM, Jones CW. Perceived impact of continuous glucose monitor use on quality of life and self-care for patients with type 2 diabetes. Diabetes Epidemiol Manag. 2022;6:100068.
Janapala RN, Jayaraj JS, Fathima N, et al. Continuous glucose monitoring versus self-monitoring of blood glucose in type 2 diabetes mellitus: a systematic review with meta-analysis. Cureus. 2019;11(9):e5634. https://doi.org/10.7759/cureus.5634.
Article PubMed PubMed Central Google Scholar
Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365–74. https://doi.org/10.7326/M16-2855.
Sierra JA, Shah M, Gill MS, et al. Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data. J Med Econ. 2018;21(3):225–30. https://doi.org/10.1080/13696998.2017.1390474.
Funtanilla VD, Candidate P, Caliendo T, et al. Continuous glucose monitoring: a review of available systems. P T. 2019;44(9):550–3.
PubMed PubMed Central Google Scholar
Boscari F, Vettoretti M, Cavallin F, et al. Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance. J Endocrinol Invest. 2022;45(1):115–24. https://doi.org/10.1007/s40618-021-01624-2.
Article CAS PubMed Google Scholar
Joseph JI. Review of the long-term implantable senseonics continuous glucose monitoring system and other continuous glucose monitoring systems. J Diabetes Sci Technol. 2021;15(1):167–73. https://doi.org/10.1177/1932296820911919.
World Health Organization. Health topics. Digital health. Date of access: 23.01.2023 https://www.who.int/health-topics/digital-health#tab=tab_1.
Bradway M, Carrion C, Vallespin B, et al. mhealth assessment: conceptualization of a global framework. JMIR Mhealth Uhealth. 2017;5(5):e60. https://doi.org/10.2196/mhealth.7291.
Article PubMed PubMed Central Google Scholar
Brod M, Kongsø JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009;18(1):23–32. https://doi.org/10.1007/s11136-008-9419-1.
Khan AM, Alswat KA. Benefits of using the i-port system on insulin-treated patients. Diabetes Spectr. 2019;32(1):30–5. https://doi.org/10.2337/ds18-0015.
Article PubMed PubMed Central Google Scholar
Tang L, Chang SJ, Chen CJ, Liu JT. Non-invasive blood glucose monitoring technology: a review. Sensors. 2020;20(23):6925. https://doi.org/10.3390/s20236925.
Article CAS PubMed PubMed Central Google Scholar
Jina A, Tierney MJ, Tamada JA, et al. Design, development, and evaluation of a novel microneedle array-based continuous glucose monitor. J Diabetes Sci Technol. 2014;8(3):483–7. https://doi.org/10.1177/1932296814526191.
Article CAS PubMed PubMed Central Google Scholar
Bandodkar AJ, Jia W, Yardımcı C, Wang X, Ramirez J, Wang J. Tattoo-based noninvasive glucose monitoring: a proof-of-concept study. Anal Chem. 2015;87(1):394–8. https://doi.org/10.1021/ac504300n.
Article CAS PubMed Google Scholar
Bruen D, Delaney C, Florea L, Diamond D. Glucose sensing for diabetes monitoring: recent developments. Sensors. 2017;17(8):1866. https://doi.org/10.3390/s17081866.
留言 (0)